Erika Cretton-Scott

581 total citations
10 papers, 423 citations indexed

About

Erika Cretton-Scott is a scholar working on Infectious Diseases, Molecular Biology and Hepatology. According to data from OpenAlex, Erika Cretton-Scott has authored 10 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Hepatology. Recurrent topics in Erika Cretton-Scott's work include HIV/AIDS drug development and treatment (9 papers), Biochemical and Molecular Research (4 papers) and Hepatitis C virus research (4 papers). Erika Cretton-Scott is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Biochemical and Molecular Research (4 papers) and Hepatitis C virus research (4 papers). Erika Cretton-Scott collaborates with scholars based in United States and France. Erika Cretton-Scott's co-authors include Gilles Gosselin, Claire Pierra, Jean‐Pierre Sommadossi, Edward G. Bridges, L Placidi, David N. Standring, Jean‐Pierre Sommadossi, Adel Moussa, Raymond F. Schinazi and John Mao and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Biochemical Pharmacology.

In The Last Decade

Erika Cretton-Scott

10 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Cretton-Scott United States 8 234 209 207 125 46 10 423
Brenda I. Hernández-Santiago United States 9 307 1.3× 119 0.6× 167 0.8× 143 1.1× 39 0.8× 16 451
Jeremy L. Clark United States 6 212 0.9× 170 0.8× 134 0.6× 148 1.2× 60 1.3× 9 343
Marina Taliani Italy 7 162 0.7× 246 1.2× 147 0.7× 115 0.9× 41 0.9× 9 384
Keith Pietropaolo United States 12 211 0.9× 194 0.9× 190 0.9× 67 0.5× 34 0.7× 33 370
Claire Pierra France 15 421 1.8× 374 1.8× 376 1.8× 258 2.1× 160 3.5× 37 763
Megan H. Powdrill Canada 10 138 0.6× 187 0.9× 157 0.8× 165 1.3× 42 0.9× 18 407
Satoshi Yuasa Japan 13 280 1.2× 179 0.9× 197 1.0× 161 1.3× 88 1.9× 34 598
Tse‐I Lin Sweden 11 276 1.2× 480 2.3× 377 1.8× 126 1.0× 63 1.4× 30 670
Margaret Gartland United States 9 201 0.9× 148 0.7× 156 0.8× 82 0.7× 27 0.6× 15 404
Constantin G. Yannopoulos Canada 11 290 1.2× 431 2.1× 229 1.1× 286 2.3× 113 2.5× 12 732

Countries citing papers authored by Erika Cretton-Scott

Since Specialization
Citations

This map shows the geographic impact of Erika Cretton-Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Cretton-Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Cretton-Scott more than expected).

Fields of papers citing papers by Erika Cretton-Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Cretton-Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Cretton-Scott. The network helps show where Erika Cretton-Scott may publish in the future.

Co-authorship network of co-authors of Erika Cretton-Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Cretton-Scott. A scholar is included among the top collaborators of Erika Cretton-Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Cretton-Scott. Erika Cretton-Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hughes, Peter J., et al.. (2011). Protease Inhibitors for Patients With HIV-1 Infection: A Comparative Overview.. PubMed. 36(6). 332–45. 28 indexed citations
3.
Pierra, Claire, Agnès Amador, S. Benzaria, et al.. (2006). Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 2‘-C-Methylcytidine. Journal of Medicinal Chemistry. 49(22). 6614–6620. 147 indexed citations
4.
Bryant, Martin L., Edward G. Bridges, L Placidi, et al.. (2001). ANTI-HBV SPECIFIC β-L-2′-DEOXYNUCLEOSIDES. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 597–607. 23 indexed citations
5.
Bryant, Martin L., Edward G. Bridges, L Placidi, et al.. (2001). Antiviral l -Nucleosides Specific for Hepatitis B Virus Infection. Antimicrobial Agents and Chemotherapy. 45(1). 229–235. 144 indexed citations
6.
Cretton-Scott, Erika, L Placidi, Abdesslem Faraj, et al.. (2000). In Vitro and In Vivo Metabolism and Pharmacokinetics ofbis[(T-Butyl)-S-acyl-2-thioethyl]-β-L-2′,3′-dideoxy-5-fluorocytidine Monophosphate. Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 481–499. 6 indexed citations
7.
Placidi, L, Erika Cretton-Scott, Gilles Gosselin, et al.. (2000). Intracellular Metabolism of β- l -2′,3′-Dideoxyadenosine: Relevance to Its Limited Antiviral Activity. Antimicrobial Agents and Chemotherapy. 44(4). 853–858. 8 indexed citations
8.
Cretton-Scott, Erika, Raymond F. Schinazi, Xiao‐Jian Zhou, et al.. (1999). Pharmacokinetics of β- l -2′,3′-Dideoxy-5-Fluorocytidine in Rhesus Monkeys. Antimicrobial Agents and Chemotherapy. 43(4). 920–924. 4 indexed citations
9.
Cretton-Scott, Erika, et al.. (1998). Role of Human Liver P450s and Cytochrome b5 in the Reductive Metabolism of 3′-Azido-3′-deoxythymidine (AZT) to 3′-Amino-3′-deoxythymidine. Biochemical Pharmacology. 55(6). 757–766. 25 indexed citations
10.
Cretton-Scott, Erika, L Placidi, Harold M. McClure, Daniel C. Anderson, & Jean‐Pierre Sommadossi. (1996). Pharmacokinetics and metabolism of O -(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys. Cancer Chemotherapy and Pharmacology. 38(2). 117–122. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026